Dr. Reddy's Laboratories Limited (RDDA) — Capital Reinvestment Ratio
Dr. Reddy's Laboratories Limited (RDDA) has a Capital Reinvestment Ratio of 0.67x as of December 2025, meaning it reinvests 1% of its operating cash flow (€10.91 Billion) in capital expenditures (€7.32 Billion). See Dr. Reddy's Laboratories Limited (RDDA) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dr. Reddy's Laboratories Limited Capital Reinvestment Ratio (2017–2025)
This chart tracks Dr. Reddy's Laboratories Limited's Capital Reinvestment Ratio across 9 annual periods. Check Dr. Reddy's Laboratories Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year Capital Reinvestment Ratio for Dr. Reddy's Laboratories Limited from 2017 to 2025. For live market cap and broader valuation context, see RDDA company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | €46.43 Billion | €34.40 Billion | ▲ +22.7% |
| 2024 | 0.60x | €45.43 Billion | €27.43 Billion | ▲ +88.4% |
| 2023 | 0.32x | €58.88 Billion | €18.87 Billion | ▼ -38.6% |
| 2022 | 0.52x | €28.11 Billion | €14.66 Billion | ▲ +91.2% |
| 2021 | 0.27x | €35.70 Billion | €9.74 Billion | ▲ +68.0% |
| 2020 | 0.16x | €29.84 Billion | €4.85 Billion | ▼ -33.0% |
| 2019 | 0.24x | €28.70 Billion | €6.96 Billion | ▼ -53.0% |
| 2018 | 0.52x | €18.03 Billion | €9.29 Billion | ▼ -9.7% |
| 2017 | 0.57x | €21.51 Billion | €12.28 Billion | — |